Financial-condition grades for SEC filers
Company Report · as of Oct 9, 2026
|
| ProtoKinetix, Inc.PKTX · healthcare | |
|---|---|
| Grade | Nonecomputable_factors_below_threshold: 2 of 14 inputs computable; 7 are required |
| Reliability | 0.76 AUCfailure model, filers with under $12.5M assets; 95% interval 0.65 to 0.86; 63 events, 2020 to 2025 |
| Peer failure rate | 0.60% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025 |
| Size band | under $12.5M assetstotal assets $483,374[1] |
| Standard universe | outsiderevenue above $1M and assets above $10M[1-2] |
| Warnings | late filer, thin data, degenerate inputsnot computable: dilution, short runway, distress, fortress balance sheet |
| Inputs computable | 2 of 14 |
| Graded from | filings received through Sep 3, 202636 days before the rescan; every figure keyed to the SEC receipt date |
| Price used in grade | None |
| Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
No price series supplied for this render. | ||||||||||||
Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date. Open this report as it stood on | ||||||||||||
Each date opens the report as it stood on that rescan. |
Business, in the company's words. Opening of Item 1 of the 10-K received Sep 3, 2026; the document on sec.gov.
“we,” “us,” “our,” or the “Company”) is a research and development stage bio-technology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins) or anti-aging glycoproteins, trademarked as AAGPs®. The Company has recently been in the process of directing major efforts to the practical side of commercial validation. The commercial applications for AAGPs® in large markets such as targeted health care solutions are numerous, and ProtoKinetix is currently working with researchers, business leaders and advisors and commercial entities to bring AAGP® to market. Inc.
7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.
Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.
| Input | Percentile, 0 to 100 | Value | Source | Peer median | Percentile | Peers | Period end |
|---|---|---|---|---|---|---|---|
| Profitability, sleeve percentile 8.0 | |||||||
| Gross profitability | not computable | 32.2% | |||||
| one or more required annual facts are missing | |||||||
| Return on invested capital | not computable | 9.3% | |||||
| one or more required annual facts are missing | |||||||
| Accruals ratio | (54.4%) | [1,3-5] | (6.6%) | 8.0 | 811 | 2025-12-31 | |
| Gross margin stability, five years | not computable | 2.8 pts | |||||
| five annual gross margins are required; found 0 | |||||||
| Solvency | |||||||
| Twelve-month failure probability | not computable | 0.07% | |||||
| liabilities and a nearby cover-page share count are required at 2025-12-31 | |||||||
| Altman Z double-prime | not computable | (0.31) | |||||
| required facts have no common fiscal period end | |||||||
| Net debt to EBITDA | not computable | 1.82x | |||||
| one or more required annual facts are missing | |||||||
| Interest coverage | not computable | (4.51x) | |||||
| interest expense must exceed $100,000 | |||||||
| Current ratio | not computable | 2.96x | |||||
| current liabilities must exceed $100,000 | |||||||
| Growth and financing, sleeve percentile 48.4 | |||||||
| Revenue growth, three-year compound | not computable | 10.0% | |||||
| four annual observations are required; found 3 | |||||||
| Free cash flow growth, three-year compound | not computable | 10.9% | |||||
| four consecutive annual FCF observations are required; found 0 | |||||||
| Reinvestment rate | not computable | 37.1% | |||||
| one or more required annual facts are missing | |||||||
| Asset growth, three years | 1.5% | [1,5-7] | 2.1% | 48.4 | 704 | 2025-12-31 | |
| Net share issuance, one year | not computable | 2.5% | |||||
| prior share count is 523 days earlier | |||||||
Gross profitability. Revenue less cost of goods sold, over total assets.
Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.
Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.
Twelve-month failure probability. CHS model; lower is stronger.
Net debt to EBITDA. Lower is stronger.
Net share issuance, one year. Split-adjusted; lower is stronger.
Market measures at the 2026-10-09 close. None enters the grade. Percentile among graded peers with the same measure.
| Measure | Value | Peer median | Percentile | Reading |
|---|---|---|---|---|
| Twelve-month price change, skipping the latest month | not computable | 8.0% | missing required 12-1 monthly returns: 2026-08, 2026-07, 2026-06, 2026-05, 2026-04, 2026-03, 2026-02, 2026-01, 2025-12, 2025-11, 2025-10 | |
| Distance from 52-week high | not computable | (31.4%) | need at least 20 price observations; found 0 | |
| EBIT to enterprise value | not computable | (1.5%) | required accounting or market input is missing | |
| Free cash flow yield | not computable | (1.0%) | required accounting or market input is missing | |
| Book value to price | not computable | 0.28 | required accounting or market input is missing | |
| Sales to price | not computable | 0.31 | required accounting or market input is missing | |
| Composite equity issuance, five years | not computable | 20.3% | required accounting or market input is missing | |
| Relative strength against the sector, log excess return | not computable | (0.14) | missing required 12-1 monthly returns: 2026-08, 2026-07, 2026-06, 2026-05, 2026-04, 2026-03, 2026-02, 2026-01, 2025-12, 2025-11, 2025-10 |
Inputs: EBIT -$916,933; book equity $297,940; sales $0; cash $57,568[8].
Diagnostics do not feed the grade.
| Piotroski F-score: None of 9, period end 2025-12-31 | ||
|---|---|---|
| Return on assets above zero | (84.4%) | ✗ fail[3,5] |
| Operating cash flow above zero | -$135,377 | ✗ fail[4] |
| Return on assets improved | (8.7 pts) | ✗ fail[3,5-6,9] |
| Operating cash flow exceeds net income | $258,273 | ✓ pass[3-4] |
| Long-term leverage fell | n/a[1,5-6] | |
| Current ratio improved | n/a[10-11] | |
| No new shares issued | n/a[8,12] | |
| Gross margin improved | n/a | |
| Asset turnover improved | n/a[5-6] | |
| Cash, filings, liquidity | |
|---|---|
| Cash and equivalents | n/a |
| Operating cash flow, four quarters | n/a[4,13-15] |
| Months of runway | not finite |
| cash is missing at the end of the latest cash-flow quarter | |
| Late filings, two years | 3 |
| NT 10-K or NT 10-Q | |
| Days since last periodic filing | 36 |
| 10-K received Sep 3, 2026 | |
| Median daily dollar volume | n/a |
| 63 sessions | |
| Days since newest grade input | 36 |
|
Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.
| # | Concept | XBRL tag | Value | Period end | Received | Form | Links |
|---|---|---|---|---|---|---|---|
| 1 | assets | us-gaap:Assets | $483,374 | 2025-12-31 | 2026-09-03 | 10-K | filing · viewer · series |
| 2 | revenue | us-gaap:Revenues | $0 | 2014-12-31 | 2015-04-14 | 10-K | filing · viewer · series |
| 3 | net income | us-gaap:NetIncomeLoss | -$393,650 | 2025-12-31 | 2026-09-03 | 10-K | filing · viewer · series |
| 4 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$135,377 | 2025-12-31 | 2026-09-03 | 10-K | filing · viewer · series |
| 5 | assets | us-gaap:Assets | $466,137 | 2024-12-31 | 2026-09-03 | 10-K | filing · viewer · series |
| 6 | assets | us-gaap:Assets | $480,557 | 2023-12-31 | 2025-03-28 | 10-K | filing · viewer · series |
| 7 | assets | us-gaap:Assets | $462,870 | 2022-12-31 | 2024-03-20 | 10-K | filing · viewer · series |
| 8 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 411,630,152 | 2026-09-02 | 2026-09-03 | 10-K | filing · viewer · series |
| 9 | net income | us-gaap:NetIncomeLoss | -$364,188 | 2024-12-31 | 2026-09-03 | 10-K | filing · viewer · series |
| 10 | current liabilities | us-gaap:LiabilitiesCurrent | $185,434 | 2025-12-31 | 2026-09-03 | 10-K | filing · viewer · series |
| 11 | current liabilities | us-gaap:LiabilitiesCurrent | $124,047 | 2024-12-31 | 2026-09-03 | 10-K | filing · viewer · series |
| 12 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 377,580,152 | 2025-03-28 | 2025-03-28 | 10-K | filing · viewer · series |
| 13 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$135,935 | 2025-09-30 | 2025-11-13 | 10-Q | filing · viewer · series |
| 14 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$132,027 | 2025-06-30 | 2025-08-13 | 10-Q | filing · viewer · series |
| 15 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$51,970 | 2025-03-31 | 2025-05-15 | 10-Q | filing · viewer · series |
Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.
Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.
Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.
Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.
Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.